Acupuncture, Moxibustion & Meridian Research Group, Medical Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
BMC Complement Altern Med. 2013 Mar 13;13:59. doi: 10.1186/1472-6882-13-59.
BACKGROUND: The treatment of knee osteoarthritis, which is a major cause of disability among the elderly, is typically selected from multidisciplinary options, including complementary and alternative medicine. Moxibustion has been used in the treatment of knee osteoarthritis in Korea to reduce pain and improve physical activity. However, there is no sufficient evidence of its effectiveness, and it cannot therefore be widely recommended for treating knee osteoarthritis. We designed a randomised controlled clinical trial to evaluate the effectiveness, safety, cost-effectiveness, and qualitative characteristics of moxibustion treatment of knee osteoarthritis compared to usual care. METHODS/DESIGNS: This is a protocol for a multicentre, pragmatic, randomised, assessor-blinded, controlled, parallel-group study. A total of 212 participants will be assigned to the moxibustion group (n = 106) and the usual care group (n = 106) at 4 clinical research centres. The participants assigned to the moxibustion group will receive moxibustion treatment of the affected knee(s) at 6 standard acupuncture points (ST36, ST35, ST34, SP9, Ex-LE04, and SP10) 3 times per week for 4 weeks (a total of 12 sessions). Participants in the usual care group will not receive moxibustion treatment during the study period. Follow-up will be performed on the 5th and 13th weeks after random allocation. Both groups will be allowed to use any type of treatment, including surgery, conventional medication, physical treatment, acupuncture, herbal medicine, over-the-counter drugs, and other active treatments. Educational material that explains knee osteoarthritis, the current management options, and self-exercise will be provided to each group. The global scale of the Korean Western Ontario and McMaster Osteoarthritis Index (K-WOMAC) will be the primary outcome measurement used in this study. Other subscales (pain, stiffness, and function) of the K-WOMAC, the Short-Form 36v2 Health Survey, the Beck Depression Inventory, the Physical Function test, Patient Global Assessment, and the Pain Numerical Rating Scale will be used as outcome variables to evaluate the effectiveness of moxibustion. Safety will be assessed at every visit. In addition, an economic evaluation and a qualitative study will be conducted as a mixed-methods approach. DISCUSSION: This trial may contribute to developing evidence for the effectiveness and safety of moxibustion for treating knee osteoarthritis. TRIAL REGISTRATION NUMBER: KCT0000130.
背景:膝骨关节炎是老年人致残的主要原因之一,其治疗通常选自多学科选择,包括补充和替代医学。在韩国,艾灸已被用于治疗膝骨关节炎,以减轻疼痛并提高身体活动能力。但是,其有效性尚无充分证据,因此不能广泛推荐用于治疗膝骨关节炎。我们设计了一项随机对照临床试验,以评估艾灸治疗与常规护理相比治疗膝骨关节炎的有效性、安全性、成本效益和定性特征。
方法/设计:这是一项多中心、实用、随机、评估者盲法、对照、平行组研究的方案。总共将有 212 名参与者在 4 个临床研究中心被分配到艾灸组(n=106)和常规护理组(n=106)。分配到艾灸组的参与者将在 6 个标准穴位(ST36、ST35、ST34、SP9、Ex-LE04 和 SP10)处接受患侧膝关节的艾灸治疗,每周 3 次,共 4 周(共 12 次)。研究期间,常规护理组的参与者将不接受艾灸治疗。随机分组后第 5 周和第 13 周进行随访。两组都将被允许使用任何类型的治疗,包括手术、常规药物、物理治疗、针灸、草药、非处方药物和其他积极治疗。将向每组提供解释膝骨关节炎、当前管理选择和自我锻炼的教育材料。本研究的主要结局测量将使用韩国西安大略和麦克马斯特骨关节炎指数(K-WOMAC)的全球量表。K-WOMAC 的其他子量表(疼痛、僵硬和功能)、简短形式 36v2 健康调查、贝克抑郁量表、物理功能测试、患者总体评估和疼痛数字评分量表将作为结局变量,以评估艾灸的疗效。每次就诊时都会评估安全性。此外,还将作为混合方法进行经济评估和定性研究。
讨论:这项试验可能有助于为艾灸治疗膝骨关节炎的有效性和安全性提供证据。
试验注册号:KCT0000130。
BMC Complement Altern Med. 2013-3-13
Infect Drug Resist. 2022-12-13
Evid Based Complement Alternat Med. 2020-9-24
Evid Based Complement Alternat Med. 2016
Medicine (Baltimore). 2016-4
J Tradit Complement Med. 2015-7-2
Evid Based Complement Alternat Med. 2015
Arch Intern Med. 2012-10-22
BMC Complement Altern Med. 2011-11-25
J Altern Complement Med. 2011-6
Clin Rheumatol. 2011-2-18
J Altern Complement Med. 2010-10
Cochrane Database Syst Rev. 2010-1-20